what is gip and glp-1 receptors Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes A New Drug Combines Five

GLP-1RA-based therapies are believed to exert antioxidant effects, protecting cells from damage and alleviating pain

Rekha Kumar, a practicing endocrinologist in NYC and Chief Medical Officer of Found, told Healthline

This information should be interpreted with a qualified healthcare provider to support a more nuanced conversation about which GLP-1 delivery method and formulation may align best with your genetic biology

Mild to moderate transient gastrointestinal side effects were the most frequently reported adverse events associated with tirzepatide treatment (nausea 12%18% vs

Kroeze, K

Phase 2 trial data published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023) reported mean weight reductions of up to approximately 24% over 48 weeks in adults with obesity notably higher than results seen with currently approved agents